{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T19:07:24Z","timestamp":1762974444233,"version":"3.45.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Artificial intelligence (AI) has gained increasing interest in supporting clinicians in patient selection, treatment planning, and prognostics. However, the current application of AI in the treatment of colorectal liver metastases (CRLM) is not clearly established and validated. This scoping review assesses the current impact of AI techniques on local therapeutic strategies for CRLM, exploring its benefits, challenges, and future directions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A comprehensive literature search in PubMed, EMBASE, Web of Science, and SCOPUS was conducted for patients with CRLM undergoing surgery or thermal ablation, along with descriptions of AI tools. Eligible studies were cohort studies or clinical trials. Data extraction focused on treatment strategies, AI techniques, clinical and radiomics parameters, and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 1464 articles, thirteen met the inclusion criteria. Eight articles regarded thermal liver ablation, and five surgical resection for CRLM. Most studies used traditional machine learning methods, such as support vector machines and random forests, combined with radiomics for predictive model building. While most studies demonstrated high performance, they frequently involved small sample sizes, and machine learning techniques often lacked robustness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AI shows promising results in improving local treatment strategies for CRLM, but further advancements are required for AI decision support tools. Future research should focus on large multicentre studies to validate AI-driven personalised colorectal liver metastases treatment strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Critical relevance statement<\/jats:title>\n                    <jats:p>This review evaluates the use of AI in colorectal liver metastases treatment for outcome prediction and treatment evaluation. Included studies used AI for segmentation and predictive modelling and were often limited by small sample-sized single-centre studies, necessitating multicentre studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>The position of AI in local colorectal liver metastases treatments is not yet established.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>AI algorithms are mostly used for predictive model building and image registration.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Studies often lack validity, limiting generalisability and implementation of AI support tools.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-025-02072-9","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T17:21:53Z","timestamp":1762968113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The influence of AI on surgical and ablative treatments for colorectal liver metastases: a review of the current literature"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0351-2581","authenticated-orcid":false,"given":"Ariadne L.","family":"van der Velden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robrecht R. M. M.","family":"Knapen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leroy","family":"Volmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorina R.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coosje A. M.","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Burgmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre L.A.J.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim E.","family":"Wildberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald M.","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Brecheisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiaan","family":"van der Leij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"2072_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3925-x","volume":"18","author":"J Engstrand","year":"2018","unstructured":"Engstrand J, Nilsson H, Str\u00f6mberg C, Jonas E, Freedman J (2018) Colorectal cancer liver metastases\u2014a population-based study on incidence, management and survival. BMC Cancer 18:78","journal-title":"BMC Cancer"},{"key":"2072_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"2072_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.canep.2014.04.004","volume":"38","author":"YR van Gestel","year":"2014","unstructured":"van Gestel YR, de Hingh IH, van Herk-Sukel MP et al (2014) Patterns of metachronous metastases after curative treatment of colorectal cancer. Cancer Epidemiol 38:448\u2013454","journal-title":"Cancer Epidemiol"},{"key":"2072_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00384-014-2085-6","volume":"30","author":"MA Elferink","year":"2015","unstructured":"Elferink MA, de Jong KP, Klaase JM, Siemerink EJ, de Wilt JH (2015) Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands. Int J Colorectal Dis 30:205\u2013212","journal-title":"Int J Colorectal Dis"},{"key":"2072_CR5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/bjc.2014.351","volume":"111","author":"FL Rojas Llimpe","year":"2014","unstructured":"Rojas Llimpe FL, Di Fabio F, Ercolani G et al (2014) Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study. Br J Cancer 111:667\u2013673","journal-title":"Br J Cancer"},{"key":"2072_CR6","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00270-018-1959-3","volume":"41","author":"MR Meijerink","year":"2018","unstructured":"Meijerink MR, Puijk RS, van Tilborg A et al (2018) Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases: a systematic review and meta-analysis. Cardiovasc Interv Radiol 41:1189\u20131204","journal-title":"Cardiovasc Interv Radiol"},{"key":"2072_CR7","first-page":"283","volume":"4","author":"GP Kanas","year":"2012","unstructured":"Kanas GP, Taylor A, Primrose JN et al (2012) Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 4:283\u2013301","journal-title":"Clin Epidemiol"},{"key":"2072_CR8","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s00423-021-02219-4","volume":"406","author":"LF Abreu de Carvalho","year":"2021","unstructured":"Abreu de Carvalho LF, Logghe B, Van Cleven S et al (2021) Local control of hepatocellular carcinoma and colorectal liver metastases after surgical microwave ablation without concomitant hepatectomy. Langenbecks Arch Surg 406:2749\u20132757","journal-title":"Langenbecks Arch Surg"},{"key":"2072_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/02656736.2021.1923836","volume":"39","author":"I Mohamad","year":"2022","unstructured":"Mohamad I, Barry A, Dawson L, Hosni A (2022) Stereotactic body radiation therapy for colorectal liver metastases. Int J Hyperth 39:611\u2013619","journal-title":"Int J Hyperth"},{"key":"2072_CR10","first-page":"331","volume":"11","author":"EP Weledji","year":"2017","unstructured":"Weledji EP (2017) Centralization of liver cancer surgery and impact on multidisciplinary teams working on stage IV colorectal cancer. Oncol Rev 11:331","journal-title":"Oncol Rev"},{"key":"2072_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ctrv.2015.06.006","volume":"41","author":"R Adam","year":"2015","unstructured":"Adam R, de Gramont A, Figueras J et al (2015) Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev 41:729\u2013741","journal-title":"Cancer Treat Rev"},{"key":"2072_CR12","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1245\/s10434-014-4163-y","volume":"22","author":"J Oxenberg","year":"2015","unstructured":"Oxenberg J, Papenfuss W, Esemuede I et al (2015) Multidisciplinary cancer conferences for gastrointestinal malignancies result in measureable treatment changes: a prospective study of 149 consecutive patients. Ann Surg Oncol 22:1533\u20131539","journal-title":"Ann Surg Oncol"},{"key":"2072_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol EJ (2019) High-performance medicine: the convergence of human and artificial intelligence. Nat Med 25:44\u201356","journal-title":"Nat Med"},{"key":"2072_CR14","unstructured":"Goodfellow I, Bengio Y, Courville, A (2016) Deep learning. Cambridge, Massachusetts, United States: MIT Press"},{"key":"2072_CR15","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1016\/S2589-7500(19)30123-2","volume":"1","author":"X Liu","year":"2019","unstructured":"Liu X, Faes L, Kale AU et al (2019) A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis. Lancet Digit Health 1:e271\u2013e297","journal-title":"Lancet Digit Health"},{"key":"2072_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-019-0447-x","volume":"25","author":"D Ardila","year":"2019","unstructured":"Ardila D, Kiraly AP, Bharadwaj S et al (2019) End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med 25:954\u2013961","journal-title":"Nat Med"},{"key":"2072_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-019-1799-6","volume":"577","author":"SM McKinney","year":"2020","unstructured":"McKinney SM, Sieniek M, Godbole V et al (2020) International evaluation of an AI system for breast cancer screening. Nature 577:89\u201394","journal-title":"Nature"},{"key":"2072_CR18","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535","journal-title":"BMJ"},{"key":"2072_CR19","doi-asserted-by":"publisher","first-page":"886517","DOI":"10.3389\/fonc.2022.886517","volume":"12","author":"BM Anderson","year":"2022","unstructured":"Anderson BM, Rigaud B, Lin YM et al (2022) Automated segmentation of colorectal liver metastasis and liver ablation on contrast-enhanced CT images. Front Oncol 12:886517","journal-title":"Front Oncol"},{"key":"2072_CR20","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221373","volume":"307","author":"YM Lin","year":"2023","unstructured":"Lin YM, Paolucci I, O\u2019Connor CS et al (2023) Ablative margins of colorectal liver metastases using deformable CT image registration and autosegmentation. Radiology 307:e221373","journal-title":"Radiology"},{"key":"2072_CR21","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1007\/s00330-024-10632-8","volume":"34","author":"YM Lin","year":"2024","unstructured":"Lin YM, Paolucci I, Albuquerque Marques Silva J et al (2024) Ablative margin quantification using deformable versus rigid image registration in colorectal liver metastasis thermal ablation: a retrospective single-center study. Eur Radiol 34:5541\u20135550","journal-title":"Eur Radiol"},{"key":"2072_CR22","doi-asserted-by":"crossref","unstructured":"Paolucci I, Albuquerque Marques Silva J, Lin YM et al (2024) Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation. Br J Surg 111:znae165","DOI":"10.1093\/bjs\/znae165"},{"key":"2072_CR23","doi-asserted-by":"publisher","first-page":"e36586","DOI":"10.1097\/MD.0000000000036586","volume":"102","author":"H Hu","year":"2023","unstructured":"Hu H, Chi JC, Zhai B, Guo JH (2023) CT-based radiomics analysis to predict local progression of recurrent colorectal liver metastases after microwave ablation. Medicine (Baltimore) 102:e36586","journal-title":"Medicine (Baltimore)"},{"key":"2072_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00270-023-03454-6","volume":"46","author":"A Shahveranova","year":"2023","unstructured":"Shahveranova A, Balli HT, Aikimbaev K, Piskin FC, Sozutok S, Yucel SP (2023) Prediction of local tumor progression after microwave ablation in colorectal carcinoma liver metastases patients by MRI radiomics and clinical characteristics-based combined model: preliminary results. Cardiovasc Interv Radiol 46:713\u2013725","journal-title":"Cardiovasc Interv Radiol"},{"key":"2072_CR25","doi-asserted-by":"publisher","first-page":"2349059","DOI":"10.1080\/02656736.2024.2349059","volume":"41","author":"A Della Corte","year":"2024","unstructured":"Della Corte A, Mori M, Calabrese F et al (2024) Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation. Int J Hyperth 41:2349059","journal-title":"Int J Hyperth"},{"key":"2072_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/02841851211060437","volume":"64","author":"M Taghavi","year":"2023","unstructured":"Taghavi M, Staal FC, Sim\u00f5es R et al (2023) CT radiomics models are unable to predict new liver metastasis after successful thermal ablation of colorectal liver metastases. Acta Radiol 64:5\u201312","journal-title":"Acta Radiol"},{"key":"2072_CR27","doi-asserted-by":"crossref","unstructured":"Granata V, Fusco R, De Muzio F et al (2022) Contrast MR-based radiomics and machine learning analysis to assess clinical outcomes following liver resection in colorectal liver metastases: a preliminary study. Cancers (Basel) 14:1110","DOI":"10.3390\/cancers14051110"},{"key":"2072_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11547-022-01477-6","volume":"127","author":"V Granata","year":"2022","unstructured":"Granata V, Fusco R, De Muzio F et al (2022) Radiomics textural features by MR imaging to assess clinical outcomes following liver resection in colorectal liver metastases. Radiol Med 127:461\u2013470","journal-title":"Radiol Med"},{"key":"2072_CR29","doi-asserted-by":"crossref","unstructured":"Granata V, Fusco R, De Muzio F et al (2022) EOB-MR based radiomics analysis to assess clinical outcomes following liver resection in colorectal liver metastases. Cancers (Basel) 14:1239","DOI":"10.3390\/cancers14051239"},{"key":"2072_CR30","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1245\/s10434-020-08991-9","volume":"27","author":"AZ Paredes","year":"2020","unstructured":"Paredes AZ, Hyer JM, Tsilimigras DI et al (2020) A novel machine-learning approach to predict recurrence after resection of colorectal liver metastases. Ann Surg Oncol 27:5139\u20135147","journal-title":"Ann Surg Oncol"},{"key":"2072_CR31","doi-asserted-by":"publisher","first-page":"e0307815","DOI":"10.1371\/journal.pone.0307815","volume":"19","author":"E Montagnon","year":"2024","unstructured":"Montagnon E, Cerny M, Hamilton V et al (2024) Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis. PLoS One 19:e0307815","journal-title":"PLoS One"},{"key":"2072_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2022.102680","volume":"84","author":"P Bilic","year":"2023","unstructured":"Bilic P, Christ P, Li HB et al (2023) The liver tumor segmentation benchmark (LiTS). Med Image Anal 84:102680","journal-title":"Med Image Anal"},{"key":"2072_CR33","unstructured":"Soler L, Hostettler A, Agnus V et al (2010) 3D image reconstruction for comparison of algorithm database: a patient specific anatomical and medical image database. https:\/\/www-sop.inria.fr\/geometrica\/events\/wam\/abstract-ircad.pdf"},{"key":"2072_CR34","doi-asserted-by":"crossref","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med 13:1","DOI":"10.1186\/s12916-014-0241-z"},{"key":"2072_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00261-020-02624-1","volume":"46","author":"M Taghavi","year":"2021","unstructured":"Taghavi M, Trebeschi S, Sim\u00f5es R et al (2021) Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases. Abdom Radiol (NY) 46:249\u2013256","journal-title":"Abdom Radiol (NY)"},{"key":"2072_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309\u2013318","journal-title":"Ann Surg"},{"key":"2072_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/SLA.0000000000002319","volume":"269","author":"KW Brudvik","year":"2019","unstructured":"Brudvik KW, Jones RP, Giuliante F et al (2019) RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases. Ann Surg 269:120\u2013126","journal-title":"Ann Surg"},{"key":"2072_CR38","first-page":"1","volume":"21","author":"S P\u00f6lsterl","year":"2020","unstructured":"P\u00f6lsterl S (2020) scikit-survival: a library for time-to-event analysis built on top of scikit-learn. J Mach Learn Res 21:1\u20136","journal-title":"J Mach Learn Res"},{"key":"2072_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0482-1","volume":"18","author":"JL Katzman","year":"2018","unstructured":"Katzman JL, Shaham U, Cloninger A, Bates J, Jiang T, Kluger Y (2018) DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med Res Methodol 18:24","journal-title":"BMC Med Res Methodol"},{"key":"2072_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/23808993.2016.1164013","volume":"1","author":"V Parekh","year":"2016","unstructured":"Parekh V, Jacobs MA (2016) Radiomics: a new application from established techniques. Expert Rev Precis Med Drug Dev 1:207\u2013226","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"2072_CR41","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","volume":"30","author":"V Kumar","year":"2012","unstructured":"Kumar V, Gu Y, Basu S et al (2012) Radiomics: the process and the challenges. Magn Reson Imaging 30:1234\u20131248","journal-title":"Magn Reson Imaging"},{"key":"2072_CR42","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749\u2013762","journal-title":"Nat Rev Clin Oncol"},{"key":"2072_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/bjs.9465","volume":"101","author":"CJ Zech","year":"2014","unstructured":"Zech CJ, Korpraphong P, Huppertz A et al (2014) Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases. Br J Surg 101:613\u2013621","journal-title":"Br J Surg"},{"key":"2072_CR44","doi-asserted-by":"publisher","first-page":"e240300","DOI":"10.1148\/ryai.240300","volume":"6","author":"AS Tejani","year":"2024","unstructured":"Tejani AS, Klontzas ME, Gatti AA et al (2024) Checklist for artificial intelligence in medical imaging (CLAIM): 2024 update. Radiol Artif Intell 6:e240300","journal-title":"Radiol Artif Intell"},{"key":"2072_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.crad.2022.09.131","volume":"78","author":"B Vasey","year":"2023","unstructured":"Vasey B, Novak A, Ather S, Ibrahim M, McCulloch P (2023) DECIDE-AI: a new reporting guideline and its relevance to artificial intelligence studies in radiology. Clin Radiol 78:130\u2013136","journal-title":"Clin Radiol"},{"key":"2072_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"RF Wolff","year":"2019","unstructured":"Wolff RF, Moons KGM, Riley RD et al (2019) PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med 170:51\u201358","journal-title":"Ann Intern Med"},{"key":"2072_CR47","doi-asserted-by":"publisher","first-page":"e082505","DOI":"10.1136\/bmj-2024-082505","volume":"388","author":"KGM Moons","year":"2025","unstructured":"Moons KGM, Damen JAA, Kaul T et al (2025) PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods. BMJ 388:e082505","journal-title":"BMJ"},{"key":"2072_CR48","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","volume":"1","author":"C Rudin","year":"2019","unstructured":"Rudin C (2019) Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nat Mach Intell 1:206\u2013215","journal-title":"Nat Mach Intell"},{"key":"2072_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41591-021-01614-0","volume":"28","author":"P Rajpurkar","year":"2022","unstructured":"Rajpurkar P, Chen E, Banerjee O, Topol EJ (2022) AI in health and medicine. Nat Med 28:31\u201338","journal-title":"Nat Med"},{"key":"2072_CR50","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.7861\/fhj.2021-0095","volume":"8","author":"J Bajwa","year":"2021","unstructured":"Bajwa J, Munir U, Nori A, Williams B (2021) Artificial intelligence in healthcare: transforming the practice of medicine. Future Health J 8:e188\u2013e194","journal-title":"Future Health J"},{"key":"2072_CR51","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1007\/s00330-019-06609-7","volume":"30","author":"G Laimer","year":"2020","unstructured":"Laimer G, Schullian P, Jaschke N et al (2020) Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation. Eur Radiol 30:2463\u20132472","journal-title":"Eur Radiol"},{"key":"2072_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jvir.2017.08.021","volume":"29","author":"W Shady","year":"2018","unstructured":"Shady W, Petre EN, Do KG et al (2018) Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol 29:268\u2013275.e1","journal-title":"J Vasc Interv Radiol"},{"key":"2072_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70735","volume":"14","author":"H Lu","year":"2025","unstructured":"Lu H, Xie X, Zeng Y et al (2025) Prognostic comparison of complete vs. incomplete radiofrequency ablation for colorectal liver metastases: a multicenter prospective study. Cancer Med 14:e70735","journal-title":"Cancer Med"},{"key":"2072_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71796-z","volume":"10","author":"GH Choi","year":"2020","unstructured":"Choi GH, Yun J, Choi J et al (2020) Development of machine learning-based clinical decision support system for hepatocellular carcinoma. Sci Rep 10:14855","journal-title":"Sci Rep"},{"key":"2072_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41746-023-00976-8","volume":"7","author":"KH Lee","year":"2024","unstructured":"Lee KH, Choi GH, Yun J et al (2024) Machine learning-based clinical decision support system for treatment recommendation and overall survival prediction of hepatocellular carcinoma: a multi-center study. NPJ Digit Med 7:2","journal-title":"NPJ Digit Med"},{"key":"2072_CR56","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1158\/1078-0432.CCR-23-3978","volume":"30","author":"JW Han","year":"2024","unstructured":"Han JW, Lee SK, Kwon JH et al (2024) A machine learning algorithm facilitates prognosis prediction and treatment selection for Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma. Clin Cancer Res 30:2812\u20132821","journal-title":"Clin Cancer Res"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02072-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-025-02072-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02072-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T19:02:56Z","timestamp":1762974176000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-025-02072-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2072"],"URL":"https:\/\/doi.org\/10.1186\/s13244-025-02072-9","relation":{},"ISSN":["1869-4101"],"issn-type":[{"type":"electronic","value":"1869-4101"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.D. reports grants or contracts from AiNed, Janssen, IQVIA, Health Holland, Horizon Europe, I3 Europe, NWO, Province Limburg, and ZonMw; payments or honoraria IQVIA, Hertek Care and policlinico Gemelli; serving in a leadership role with the Hanarth Fund, the MD Anderson Cancer Center (Houston, TX, USA), UHN (Toronto, ON, Canada), the Novo Nordisk Foundation (Copenhagen, Denmark), and the Luxemburg National Research Fund (Esch-sur-Alzette, Luxembourg), and ZonMW (The Hague, The Netherlands); royalties or licences from Mirada Medical; and stock options\/other financial interest in Medical Data Works. All are outside the submitted work. J.W. declares speaker\u2019s fee from Bayer and Siemens (paid to institution) and declares institutional grants of Adora\/Oldelft, Anaconda, Bard, Bayer, Bentley, Boston, Brainlab, GE, Inari Medical, Johnson & Johnson, Merit Medical, Nico-Lab, Philips, Sectra, Siemens and Stryker (paid to Clinical Trial Center Maastricht). All are outside the submitted work. R.D.: research grants and study materials from Abbott Laboratories, Guerbet. All are outside the submitted work. The rest of the authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"253"}}